Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
39695 POSTS 0 COMMENTS
Athletes may take longer to recover after a concussion if they had psychosomatic symptoms before their head injury

Preexisting Mental Distress Can Slow Concussion Recovery

0
If psychosomatic symptoms present before injury, it took twice as long for most athletes to improve
Botulinum toxin is a safe and effective treatment for chronic migraine and three other neurological disorders

AAN: Botulinum Toxin Approved for Use in Chronic Migraine

0
American Academy of Neurology issues new guideline on use of the drug
Alcohol

Stomach CA Risk Up With Alcohol, Processed Meat Consumption

0
Excess weight also seems to increase chances of disease, and risk increases as three factors increase
Fractional carbon dioxide laser therapy combined with topical antifungal is effective in the treatment of onychomycosis

Laser Plus Topical Antifungal Effective for Onychomycosis

0
At six months of follow-up, 80 percent receiving combo therapy were culture-negative
Comorbidity burden is strongly and independently associated with pathological upgrading/up staging in men with clinically low-risk prostate cancer

Comorbidity Tied to Prostate Cancer Upgrading, Up Staging

0
Findings among men with clinically low-risk prostate cancer
Children who are allergic to cow's milk may have lower bone mineral density than those with other food allergies

Cow’s Milk Allergy in Childhood May Lead to Lower Bone Density

0
Low density found in 6 percent of those with allergy compared to 0 percent of childen without allergy
Patients with colorectal

Improved Survival for Certain Cancers With Low-Dose Aspirin

0
Improved odds seen for patients with colon, prostate, or breast tumors, but research isn't definitive
There is no solid evidence for the effectiveness of pre-participation screening in reducing the number of sudden cardiac deaths among young athletes

No Solid Evidence for Pre-Participation Screens in Athletes

0
Few people at risk for sudden cardiac death identified with the most basic type of screening
Pembrolizumab is associated with an overall objective response rate of 33 percent in patients with advanced melanoma

Pembrolizumab Active in Patients With Advanced Melanoma

0
Overall response rate of 33 percent for total population, 45 percent among treatment naive
For patients with primary angle-closure and primary angle-closure glaucoma

Relative Lens Vault Predicts Post-Op Refractory Error

0
Pre-op relative lens vault significantly predicts refractive outcome after cataract surgery